Study #2024-1879
A phase I study of the NovoTTF-200M and Novo TTF-200A systems for the treatment of refractory spinal metastasis
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This clinical research study is to learn about the safety of the NovoTTF-200M and Novo TTF-200A Systems, when used either alone or in combination with standard therapy, in patients with tumors that did not respond to treatment.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Spinal Metastasis
Study phase:
Phase I
Physician name:
Claudio Tatsui
Department:
Neurosurgery
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.?